## 






## 

## 

## 

## 

## 



## 

## 

## 

## 

## 



## 

## 

## 

## 



## 

## 

## 

## 



## 

## 

## 

## 



## 

||||||31.12.21|31.12.20|
|---|---|---|---|---|---|---|
||||Unrestricted|Restricted|Total|Total|
||||fund|fund|funds|funds|
|||Notes|f||||
|INCOME AND ENDOWMENTS FROM|||||||
|Charitable<br>activities|||||||
|To advance the science|and art ofgynaecological||||||
|oncology for the benefit ofthe public|||218,991||218)991|51,532|
|Investment<br>income|||14||14|144|
|Other income|||553||553||
|Total|||219,558||219,558|51,676|
|EXPENDITURE ON|||||||
|Charitable<br>activities||4|||||
|To advance the science|and art ofgynaecological||||||
|oncology for the benefit ofthe public|||88,013||88,013|77,229|
|NET INCOME/(EXPENDITURE)|||131,545||131,545|(25,553)|
|RECONCILIATION|OF FUNDS||||||
|Total funds brought<br>forward|||441,466||441,466|467,019|
|TOTAL FUNDS CARRIED FORWARD|||573,011||573,011|441,466|





## 

|||||31.12.21|31.12.20|
|---|---|---|---|---|---|
|||Unrestricted|Restricted|Total|Total|
|||fund|fund|funds|funds|
||Notes||f,|8||
|CURRENT ASSETS||||||
|Debtors|9|107,379||107,379|2,040|
|Cash at bank||476,082||476,082|453,469|
|||583,461||583,461|455,509|
|CREDITORS||||||
|Amounts<br>falling due within one year|10|(10,450)||(10,450)|(14,043)|
|NET CURRENT ASSETS||573,011||573,011|441,466|
|TOTAL ASSETSLESSCURRENT||||||
|LIABILITIES||573,011||573,011|441,466|
|NET ASSETS||573,011||573,011|441,466|
|FUNDS||||||
|Unrestricted<br>funds||||573,011|441,466|
|TOTAL FUNDS||||573,011|441,466|





## 

## 

## 

## 

## 

## 




|3.|INCOME FROM CHARITABLE ACTIVITIES|INCOME FROM CHARITABLE ACTIVITIES|INCOME FROM CHARITABLE ACTIVITIES|INCOME FROM CHARITABLE ACTIVITIES|INCOME FROM CHARITABLE ACTIVITIES|INCOME FROM CHARITABLE ACTIVITIES|||
|---|---|---|---|---|---|---|---|---|
||||||||31.12.21|31.12.20|
||||||Activity||||
||||||To advance the|science and art of|||
||||||gynaecological|oncology for the benefit of|||
||Sponsorships||||the public||88,400|6,883.|
||||||To advance the|science and art of|||
||||||gynaecological|oncology for the benefit of|||
||Delegate fees||||the public||$1)285|785|
||||||To advance the|science and art of|||
||||||gynaecological|oncology for the benefit of|||
||Subscriptions||||the public||49,306|43,864|
||||||||218,991|51,532|
|4.|CHARITABLE|||ACTIVITIES COSTS|||||
||||||||Support||
|||||||Direct|costs (see||
|||||||Costs|note 5)|Totals|
||To advance|the|science and art of||||||
||gynaecological||oncology||for the benefit||||
||ofthe public|||||69,653|18,360|8$,013|
|5.|SUPPORT|COSTS|||||||
||||||||Governance||
|||||||Management|costs<br>f|Totals|
||To advance|the|science and art of||||||
||gynaecological||oncology||for the benefit of||||
||the public|||||16,281|2,079|1$,360|
|6.|INDEPENDENT|||EXAMINER'S FEES|||||
||||||||31.12.21|31.12.20|
||||||||f||
||Independent|examiner's|||fees||2,079|1,500|
||Other assurance||services|||||500|





## 

## 

|ended 31 December 20|20.|||||
|---|---|---|---|---|---|
|Trustees'<br>expenses||||||
|||||31.12.21|31.12.20|
|||||8||
|Trustees' expenses|||||516|
|COMPARATIVES FORTHE STATEMENT OF FINANCIAL ACTIVITIES||||||
||||Unrestricted|Restricted|Total|
||||fund|fund|funds|
||||f|f,||
|INCOME AND ENDOWMENTS||FROM||||
|Charitable<br>activities||||||
|To advance the science|and art of|||||
|gynaecological<br>oncology for the benefit ofthe||||||
|public|||51,532||51,532|
|Investment<br>income|||||144|
|Total|||51,676||51,676|
|EXPENDITURE ON||||||
|Charitable<br>activities||||||
|To advance the science|and art of|||||
|gynaecological<br>oncology for the benefit ofthe||||||
|public|||77,229||77,229|
|NET INCOME/(EXPENDITURE)|||(25,553)||(25,553)|
|RECONCILIATION|OF FUNDS|||||
|Total funds brought<br>forward|||467,019||467,019|
|TOTAL FUNDS CARRIED FORWARD|||441,466||441,466|





|9.|DEBTORS:|AMOUNTS FALLING DUE WITHIN ONE YEAR|AMOUNTS FALLING DUE WITHIN ONE YEAR|AMOUNTS FALLING DUE WITHIN ONE YEAR|||
|---|---|---|---|---|---|---|
||||||31.12.21|31.12.20|
|||||||f|
||Other debtors||||105,032||
||Prepayments||||2,347|2,040|
||||||107,379|2,040|
|10.|CREDITORS:||AMOUNTS FALLING DUE WITHIN ONE YEAR||||
||||||31.12.21|31.12.20|
||VAT||||7,260|1,289|
||Other creditors||||1,191|11,254|
||Accrued expenses||||1,999|1,500|
||||||10,450|14,043|
|11.|MOVEMENT||IN FUNDS||||
||||||Net||
||||||movement|At|
|||||At 1.1.21|in funds|31.12.21|
|||||||f|
||Unrestricted|funds|||||
||General fund|||441,466|131,545|573,011|
||TOTAL FUNDS|||441,466|131,545|573,011|
||Net movement||in funds, included|in the above are as follows:|||
|||||Incoming|Resources|Movement|
|||||resources|expended|in funds|
||Unrestricted|funds|||||
||General fund|||219,558|(88,013)|131,545|
||TOTAL FUNDS|||219,558|(88,013)|131,545|





## 

|||||Net||
|---|---|---|---|---|---|
|||||movement|At|
||||At 1.1.20|in funds|31.12.20|
|||||6||
|Unrestricted|funds|||||
|General fund|||467,019|(25,553)|441,466|
|TOTAL FUNDS|||467,019|(25,553)|441,466|
|Comparative|net movement|in funds, included|in the above are as follows:|||
||||Incoming|Resources|Movement|
||||resources|expended|in funds|
|Unrestricted|funds|||||
|General fund|||51,676|(77,229)|(25,553)|
|TOTAL FUNDS|||51,676|(77,229)|(25,553)|



||||Net||
|---|---|---|---|---|
||||movement|At|
|||At 1.1.20|in funds|31.12.21|
||||f||
|Unrestricted|funds||||
|General fund||467,019|105,992|573,011|
|TOTAL FUNDS||467,019|105,992|573,011|



||||Incoming|Resources|Movement|
|---|---|---|---|---|---|
||||resources|expended|in funds|
|Unrestricted||funds||||
|General|fund||271,234|(165,242)|105,992|
|TOTAL|FUNDS||271,234|(165,242)|105,992|





## 

##